RP Digital

Subscribe

RP Digital

BioCryst stock rises after $264 million sale of European ORLADEYO business

1 min0



BioCryst stock rises after $264 million sale of European ORLADEYO business



Source link

rpdigital

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles